πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Area in which the carrier system is most dense is called as…………..
  • (A) Therapeutic window
  • (B) Absorption index
  • (C) Therapeutic index
  • (D) Absorption window
πŸ’¬ Discuss
βœ… Correct Answer: (D) Absorption window
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. ………types of drugs are absorbed by pore transport mechanism.
  • (A) Macromolecules
  • (B) Ionic drugs
  • (C) Drugs with molecular weight 100-400
  • (D) Water soluble drugs of molecular weight less than 100
πŸ’¬ Discuss
βœ… Correct Answer: (D) Water soluble drugs of molecular weight less than 100
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. In carrier mediated transport energy is derived from……..
  • (A) Hydrolysis of ATP
  • (B) Protein metabolism
  • (C) Concentration gradient
  • (D) All of the above
πŸ’¬ Discuss
βœ… Correct Answer: (A) Hydrolysis of ATP
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Very weak bases having pKa < 5
  • (A) Are ionized in the entire pH range of GIT
  • (B) Show absorption, which is pH dependent
  • (C) Are unionized at all pH values
  • (D) None of the above
πŸ’¬ Discuss
βœ… Correct Answer: (C) Are unionized at all pH values
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. According to pH partition theory, a weak acidic drug will most likely be absorbed from the stomach because the drug which exist primarily in the
  • (A) Unionized, more lipid soluble form
  • (B) Ionised, more water soluble form
  • (C) Form of weak acid and more soluble in acid media
  • (D) Ionic form of the drug, which facilitates diffusion
πŸ’¬ Discuss
βœ… Correct Answer: (A) Unionized, more lipid soluble form
πŸ“Š Biopharmaceutics and Pharmacokinetic
Q. Which of the following is not an approach for overcoming bioavailability problems?
  • (A) Pharmaceutic approach
  • (B) Pharmacokinetic approach
  • (C) Biologic approach
  • (D) Partition coefficient approach
πŸ’¬ Discuss
βœ… Correct Answer: (D) Partition coefficient approach